Signaling proteins ERK1/2, CREB, Src, and AKT, which are frequently altered in pancreatic cancer, were phosphorylated and thus activated in response to both acute and chronic nicotine treatment, and this could be abrogated by treatment with the β-AR agonist propranolol. Here, CREB1 is linked to pancreatic neoplasm.